Bernadette Atzwanger-Liegl

Graz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib-A Case Report.

ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib-A Case Report.

Journal: JCO precision oncology

Published: June 18, 2026

Conclusiveness of biopsy techniques for diagnosis of bone and soft tissue tumours: a retrospective, single-centre observational study.

Conclusiveness of biopsy techniques for diagnosis of bone and soft tissue tumours: a retrospective, single-centre observational study.

Journal: Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology

Published: March 04, 2026

Feasibility and workflow analysis of confocal microscopy in robot-assisted prostatectomy.

Feasibility and workflow analysis of confocal microscopy in robot-assisted prostatectomy.

Journal: BJU international

Published: February 08, 2026

Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma Registry.

Nationwide treatment patterns and outcomes of localised soft tissue sarcoma in Austria: real-world data from the Austrian Sarcoma Registry.

Journal: Journal of orthopaedic surgery and research

Published: November 13, 2025

Tumor cells seeding in biopsy tracts after open biopsy in three patients with chondrosarcoma-Case reports.

Tumor cells seeding in biopsy tracts after open biopsy in three patients with chondrosarcoma-Case reports.

Journal: Wiener klinische Wochenschrift

Published: October 27, 2025

MRI-based deep learning and radiomics pipeline for myxoid liposarcoma: a feasibility study in a rare sarcoma.

MRI-based deep learning and radiomics pipeline for myxoid liposarcoma: a feasibility study in a rare sarcoma.

Journal: Scientific reports

Published: July 30, 2025

Resurfacing Threats: Metastatic Ossifying Fibromyxoid Tumor Emerging After Almost Two Decades.

Resurfacing Threats: Metastatic Ossifying Fibromyxoid Tumor Emerging After Almost Two Decades.

Journal: Genes, chromosomes & cancer

Published: May 01, 2025

Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspects.

Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspects.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 10, 2025

Glioblastoma targeting by water-soluble hypericin derivate HHL-PVP and photodynamic tumour killing.

Glioblastoma targeting by water-soluble hypericin derivate HHL-PVP and photodynamic tumour killing.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 07, 2025

Drug screening reveals differential drug response in primary and metastatic clear cell sarcoma.

Drug screening reveals differential drug response in primary and metastatic clear cell sarcoma.

Journal: Cancer letters

Published: December 30, 2024

Incidence of and survival with bone and soft tissue sarcoma: A nation-wide study over four decades.

Incidence of and survival with bone and soft tissue sarcoma: A nation-wide study over four decades.

Journal: Cancer communications (London, England)

Published: October 13, 2024

New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas.

New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas.

Journal: Oncology research and treatment

Published: August 30, 2024

Showing 1-12 of 109

Last Updated: 09/26/2026